pembrolizumab,favezelimab
merck
['pembro', 'mk-4280', 'keyform-008', 'favezelimab', 'cml']
armand. lag3-inh favezelimab+pembro.
relative efficacy of favezelumab?
mk-4280-003 cohort 2 compared to keynote-087. anti pd-1-refractory pts.
orr 37 vs 2%. keyform-008 ongoing. happy to participate. #17icml 
Oncologist at Uppsala university hospital. Chair of the Swedish lymphoma group (SLG) and the Swedish Hodgkin lymphoma group.